U.S. Pharmaceutical Sales - Q4 2011
The following is a list of the top 100 prescribed medicines by US National Sales in Q4 2011. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q4 2011 by units sold
Rank |
Drug |
Units (000) |
|
|
1 ( 1) |
budesonide Generic |
13,397 |
48.34% |
Stats |
2 ( 1) |
acetaminophen/hydrocodone Generic |
9,464 |
0.72% |
Stats |
3 ( 2) |
OneTouch
|
7,045 |
1.21% |
Stats |
4 |
Nexium AstraZeneca |
7,005 |
-1.60% |
Stats |
5 ( 2) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
6,968 |
-5.70% |
Stats |
6 |
Singulair Merck |
6,888 |
3.30% |
Stats |
7 ( 2) |
Cymbalta
|
6,061 |
3.47% |
Stats |
8 ( 2) |
Advair Diskus GlaxoSmithKline |
5,888 |
3.57% |
Stats |
9 ( 1) |
Lantus Sanofi |
5,888 |
-1.09% |
Stats |
10 ( 1) |
Plavix
|
5,239 |
-1.49% |
Stats |
11 ( 4) |
Lipitor
|
4,950 |
-21.39% |
Stats |
12 |
fentanyl Generic |
4,243 |
-4.76% |
Stats |
13 ( 1) |
Crestor AstraZeneca |
4,077 |
4.62% |
Stats |
14 ( 1) |
AndroGel AbbVie Inc. |
3,905 |
-4.80% |
Stats |
15 |
Lantus Solostar Sanofi |
3,482 |
7.07% |
Stats |
16 ( 20) |
enoxaparin Generic |
3,469 |
118.86% |
Stats |
17 ( 1) |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
3,218 |
2.48% |
Stats |
18 ( 1) |
Novolog Novo Nordisk |
2,873 |
-0.48% |
Stats |
19 ( 3) |
Nasonex Merck |
2,676 |
8.08% |
Stats |
20 |
Humalog Eli Lilly and Company |
2,673 |
2.81% |
Stats |
21 |
Abilify Otsuka Pharmaceutical Co., Ltd |
2,569 |
2.80% |
Stats |
22 ( 1) |
Levemir Novo Nordisk |
2,532 |
5.02% |
Stats |
23 ( 1) |
metoprolol Generic |
2,525 |
6.27% |
Stats |
24 ( 6) |
Actos Takeda Pharmaceutical Company Limited |
2,197 |
-19.67% |
Stats |
25 ( 2) |
NovoLog FlexPen Novo Nordisk |
2,187 |
6.73% |
Stats |
26 ( 1) |
Lexapro
|
2,137 |
-1.84% |
Stats |
27 ( 1) |
Diovan Novartis Pharmaceuticals Corporation |
2,134 |
1.43% |
Stats |
28 |
Januvia Merck |
2,133 |
4.35% |
Stats |
29 ( 1) |
Lyrica
|
2,032 |
1.25% |
Stats |
30 ( 1) |
Namenda
|
2,017 |
-0.44% |
Stats |
31 |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
2,014 |
2.03% |
Stats |
32 |
Zetia Merck |
1,944 |
-0.10% |
Stats |
33 ( 2) |
Flovent HFA GlaxoSmithKline |
1,922 |
16.13% |
Stats |
34 ( 1) |
Suboxone
|
1,823 |
1.73% |
Stats |
35 ( 8) |
Symbicort AstraZeneca |
1,752 |
17.58% |
Stats |
36 ( 2) |
Seroquel AstraZeneca |
1,746 |
1.10% |
Stats |
37 ( ) |
atorvastatin Generic |
1,740 |
n/a |
Stats |
38 ( 1) |
Lidoderm Endo Pharmaceuticals Inc. |
1,666 |
5.91% |
Stats |
39 |
Lovaza GlaxoSmithKline |
1,610 |
2.88% |
Stats |
40 ( 2) |
Benicar Daiichi Sankyo |
1,499 |
-0.86% |
Stats |
41 |
Vytorin Merck |
1,415 |
-6.66% |
Stats |
42 ( 4) |
Remicade Janssen Pharmaceuticals, Inc. |
1,414 |
-9.82% |
Stats |
43 ( 4) |
Restasis Allergan plc |
1,341 |
4.60% |
Stats |
44 ( 1) |
Diovan HCT Novartis Pharmaceuticals Corporation |
1,300 |
-1.52% |
Stats |
45 ( 1) |
OxyContin Purdue Pharma LP |
1,279 |
-1.69% |
Stats |
46 ( 2) |
Lovenox Sanofi |
1,097 |
-3.60% |
Stats |
47 ( 2) |
Niaspan AbbVie Inc. |
1,076 |
-4.78% |
Stats |
48 ( ) |
olanzapine Generic |
1,034 |
n/a |
Stats |
49 ( 1) |
Celebrex
|
1,033 |
1.47% |
Stats |
50 ( 2) |
VESIcare Astellas Pharma US, Inc. |
971 |
2.86% |
Stats |
51 ( 6) |
Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc. |
949 |
16.30% |
Stats |
52 ( 1) |
TriCor AbbVie Inc. |
937 |
-2.29% |
Stats |
53 ( 1) |
Janumet Merck |
905 |
4.26% |
Stats |
54 ( 1) |
Evista
|
905 |
-2.06% |
Stats |
55 |
Enbrel Amgen Inc. |
863 |
1.77% |
Stats |
56 |
Aciphex Eisai Inc. |
832 |
-1.54% |
Stats |
57 ( 2) |
Vyvanse Takeda Pharmaceutical Company Limited |
760 |
13.26% |
Stats |
58 |
Geodon
|
700 |
-1.69% |
Stats |
59 ( 3) |
methylphenidate Generic |
687 |
15.85% |
Stats |
60 |
Epogen Amgen Inc. |
669 |
3.40% |
Stats |
61 ( 2) |
amphetamine/dextroamphetamine Generic |
643 |
8.98% |
Stats |
62 ( 18) |
Zyprexa
|
614 |
-54.89% |
Stats |
63 ( 1) |
Cialis Eli Lilly and Company |
606 |
8.60% |
Stats |
64 ( 3) |
Rebif EMD Serono, Inc. |
594 |
-0.34% |
Stats |
65 |
Humira AbbVie Inc. |
562 |
2.55% |
Stats |
66 |
Truvada Gilead Sciences, Inc. |
561 |
3.31% |
Stats |
67 |
Rituxan Genentech, Inc. |
552 |
4.74% |
Stats |
68 |
Provigil
|
508 |
-2.68% |
Stats |
69 |
Atripla Gilead Sciences, Inc. |
482 |
4.78% |
Stats |
70 |
Avastin Genentech, Inc. |
470 |
3.52% |
Stats |
71 ( 1) |
Viagra
|
464 |
3.11% |
Stats |
72 ( 1) |
Seroquel XR AstraZeneca |
459 |
2.00% |
Stats |
73 ( 1) |
Adderall XR Takeda Pharmaceutical Company Limited |
399 |
1.79% |
Stats |
74 ( 1) |
Lunesta Sunovion Pharmaceuticals Inc. |
367 |
-0.27% |
Stats |
75 ( 2) |
Neulasta Amgen Inc. |
326 |
3.49% |
Stats |
76 |
Aranesp Amgen Inc. |
318 |
-3.64% |
Stats |
77 ( 2) |
Procrit Janssen Pharmaceuticals, Inc. |
308 |
3.01% |
Stats |
78 ( 3) |
Reyataz Bristol-Myers Squibb Company |
289 |
3.21% |
Stats |
79 ( 1) |
Solodyn Medicis Pharmaceutical Corporation |
286 |
-7.74% |
Stats |
80 ( 7) |
Varivax Merck |
263 |
-36.93% |
Stats |
81 ( 2) |
Eloxatin Sanofi |
259 |
9.75% |
Stats |
82 |
Erbitux Eli Lilly and Company |
256 |
0.79% |
Stats |
83 ( 3) |
Isentress Merck |
239 |
6.22% |
Stats |
84 |
Lucentis Genentech, Inc. |
238 |
2.59% |
Stats |
85 |
Copaxone Teva Pharmaceuticals USA, Inc. |
229 |
0.88% |
Stats |
86 ( 1) |
Opana ER Endo Pharmaceuticals Inc. |
226 |
5.61% |
Stats |
87 ( 2) |
Prezista Janssen Pharmaceuticals, Inc. |
199 |
7.57% |
Stats |
88 ( 4) |
Neupogen Amgen Inc. |
175 |
10.76% |
Stats |
89 ( 2) |
Alimta Eli Lilly and Company |
175 |
3.55% |
Stats |
90 ( ) |
Synagis MedImmune, Inc. |
173 |
n/a |
Stats |
91 ( 1) |
Prevnar 13 Pfizer Inc. |
164 |
-7.87% |
Stats |
92 ( 1) |
Herceptin Genentech, Inc. |
155 |
4.73% |
Stats |
93 ( 3) |
Velcade Takeda Pharmaceutical Company Limited |
142 |
4.41% |
Stats |
94 |
Zyvox Pfizer Inc. |
140 |
n/a |
Stats |
95 |
Avonex Biogen Inc. |
135 |
-2.17% |
Stats |
96 ( 1) |
Gleevec Novartis Pharmaceuticals Corporation |
86 |
3.61% |
Stats |
97 ( ) |
Pegasys Genentech, Inc. |
84 |
n/a |
Stats |
98 |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
75 |
-5.06% |
Stats |
99 |
Xeloda Genentech, Inc. |
69 |
n/a |
Stats |
100 |
Incivek Vertex Pharmaceuticals Incorporated |
29 |
31.82% |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.